# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-103192
Filing Date
2025-08-05
Accepted
2025-08-05 16:57:29
Documents
99
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bbio-20250630.htm iXBRL | 10-Q | 5210671
2 | EX-10.1 | bbio-ex10_1.htm | EX-10.1 | 836061
3 | EX-10.2 | bbio-ex10_2.htm | EX-10.2 | 1162285
4 | EX-31.1 | bbio-ex31_1.htm | EX-31.1 | 29895
5 | EX-31.2 | bbio-ex31_2.htm | EX-31.2 | 29991
6 | EX-31.3 | bbio-ex31_3.htm | EX-31.3 | 28387
7 | EX-32.1 | bbio-ex32_1.htm | EX-32.1 | 13605
8 | EX-32.2 | bbio-ex32_2.htm | EX-32.2 | 13892
9 | EX-32.3 | bbio-ex32_3.htm | EX-32.3 | 13227
| Complete submission text file | 0000950170-25-103192.txt |  | 24175453

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
10 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | bbio-20250630.xsd | EX-101.SCH | 2787479
102 | EXTRACTED XBRL INSTANCE DOCUMENT | bbio-20250630_htm.xml | XML | 4945922

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 251185861
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)